Neuroblastoma
📧 Sign up to get email alerts when something new happens for Neuroblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-10-29Clinical Trial Update: Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma [Phase 2]
Phase 2 clinical trial evaluating a combination of cyclophosphamide, topotecan, and bevacizumab (CTB) in relapsed/refractory neuroblastoma a…
-
CLINICAL_TRIALS trial_result · 2019-10-09Clinical Trial Update: High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of First Remission After Myeloablative Therapy and Autologous Stem-Cell Transplantation [Phase 2]
A Phase 2 clinical trial evaluating high-dose 3F8/GM-CSF immunotherapy plus 13-cis-retinoic acid as consolidation therapy after autologous s…
-
CLINICAL_TRIALS trial_result · 2019-08-29Clinical Trial Update: Lorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma [Phase 2]
Phase 2 trial update for Lorvotuzumab Mertansine in several relapsed/refractory pediatric solid tumors; study completed with results posted …
-
CLINICAL_TRIALS trial_result · 2019-08-13Clinical Trial Update: 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Primary Refractory Neuroblastoma in Bone Marrow [Phase 2]
Phase 2 trial evaluating 3F8/GM-CSF immunotherapy with 13-cis-retinoic acid for primary refractory neuroblastoma in bone marrow has complete…
-
CLINICAL_TRIALS trial_result · 2019-08-13Clinical Trial Update: 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of First Remission After Non-Myeloablative Therapy in Patients With High-Risk Neuroblastoma [Phase 2]
Phase 2 trial evaluating 3F8/GM-CSF immunotherapy plus 13-cis-retinoic acid as consolidation therapy after non-myeloablative therapy in high…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-08-05Clinical Trial Update: Post-Marketing Assessment of Immunogenicity and Safety of Unituxin® in High-Risk Neuroblastoma Patients
Post-marketing assessment report on immunogenicity and safety of Unituxin in high-risk neuroblastoma patients; study terminated with results…
-
CLINICAL_TRIALS trial_result · 2019-07-31Clinical Trial Update: Study of MLN8237 in Combination With Irinotecan and Temozolomide [Phase 1, Phase 2]
Phase 1/2 trial evaluating MLN8237 in combination with irinotecan and temozolomide for neuroblastoma has completed and results posted.
-
CLINICAL_TRIALS trial_result · 2019-07-23Clinical Trial Update: Study of Donor Derived, Multi-virus-specific, Cytotoxic T-Lymphocytes for Relapsed/Refractory Neuroblastoma [Phase 1]
Phase 1 trial evaluating donor-derived multi-virus-specific cytotoxic T-lymphocytes for relapsed/refractory neuroblastoma has completed with…
-
CLINICAL_TRIALS trial_result · 2019-05-31Clinical Trial Update: Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or Neuroblastoma [Phase 3]
A Phase 3 clinical trial evaluating meta-iodobenzylguanidine (123I mIBG) scintigraphy in patients being evaluated for pheochromocytoma or ne…
-
CLINICAL_TRIALS trial_result · 2019-05-10Clinical Trial Update: Autologous Stem Cell Rescue With CD133+ Selected Cells in High-Risk Neuroblastoma [Phase 2, Phase 3]
Clinical trial update for autologous stem cell rescue with CD133+ selected cells in high-risk neuroblastoma; study terminated with results p…
-
CLINICAL_TRIALS trial_result · 2019-03-27Clinical Trial Update: Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating double cord blood transplant for malignant and non-malignant disorders; study terminated with results po…
-
CLINICAL_TRIALS trial_result · 2019-02-28Clinical Trial Update: Study of Safety and Efficacy in Patients With Malignant Rhabdoid Tumors (MRT) and Neuroblastoma [Phase 1]
Phase 1 trial investigating safety and efficacy in malignant rhabdoid tumors and neuroblastoma; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2019-01-29Clinical Trial Update: Activated T Cells Armed With GD2 Bispecific Antibody in Children and Young Adults With Neuroblastoma and Osteosarcoma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating activated T cells armed with a GD2 bispecific antibody to treat disseminated or recurrent neuroblastoma …
-
CLINICAL_TRIALS trial_result · 2018-12-27Clinical Trial Update: Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors [Phase 1, Phase 2]
A pediatric Phase 1/2 study assessed the safety and early activity of weekly nab-paclitaxel in children with recurrent or refractory solid t…
-
CLINICAL_TRIALS trial_result · 2018-10-17Clinical Trial Update: G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor [Phase 4]
A Phase 4 clinical trial evaluating G-CSF alone or in combination with GM-CSF for prevention and treatment of infection in children with mal…
-
CLINICAL_TRIALS trial_result · 2018-09-18Clinical Trial Update: Haploidentical Stem Cell Transplantation and NK Cell Therapy in Patients With High-risk Solid Tumors [Phase 2]
Phase 2 clinical trial evaluating haploidentical stem cell transplantation with NK cell therapy in high-risk solid tumors, including neurobl…
-
CLINICAL_TRIALS trial_result · 2018-09-18Clinical Trial Update: Tandem High-dose Chemotherapy and Autologous Stem Cell Rescue in Patients With High-risk Neuroblastoma [Phase 2]
Phase 2 clinical trial update of tandem high-dose chemotherapy with autologous stem cell rescue in patients with high-risk neuroblastoma.
-
CLINICAL_TRIALS trial_result · 2018-09-18Clinical Trial Update: Tandem High Dose Chemotherapy With 131I-MIBG Treatment in High Risk Neuroblastoma [Phase 2]
Clinical trial update for tandem high-dose chemotherapy with 131I-MIBG treatment in high-risk neuroblastoma (Phase 2).
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Allogeneic Stem Cell Transplantation for Advanced Neuroblastoma Using MHC Mismatched Related Donors [Phase 1]
Phase 1 clinical trial evaluating safety and feasibility of allogeneic stem cell transplantation from MHC-mismatched related donors in patie…
-
CLINICAL_TRIALS research · 2018-03-30Clinical Trial Update: Immunotherapy of Neuroblastoma Patients Using a Combination of Anti-GD2 and NK Cells [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating a combination of an anti-GD2 antibody and natural killer (NK) cells for recurrent neuroblastoma.
-
CLINICAL_TRIALS trial_result · 2018-03-21Clinical Trial Update: HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors [Phase 1]
This update reports the completion of a Phase 1 clinical trial evaluating HSV-1716 in patients with non-CNS solid tumors, including rhabdomy…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors [Phase 1]
A Phase 1 trial evaluating amifostine to protect against side effects of peripheral stem cell transplantation in patients with solid tumors …
-
CLINICAL_TRIALS withdrawal · 2017-11-24Clinical Trial Update: A Vaccine Study for High Risk Cancers [Phase 1]
A Phase 1 cancer vaccine study has been withdrawn; it targeted neuroblastoma, rhabdomyosarcoma, and osteosarcoma.
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: A Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell Transplantation [Phase 2]
A Phase 2 pilot trial evaluated a tumor cell vaccine in high-risk solid tumor patients after stem cell transplantation, and the study has co…
-
CLINICAL_TRIALS trial_result · 2017-09-28Clinical Trial Update: Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin [Phase 1]
Phase 1 trial assessing induction therapy with 131I-MIBG plus chemotherapy for newly diagnosed high-risk neuroblastoma patients undergoing s…